Thursday 16 February 2012

Eli Lilly on Launch of Humapen Luxura Hd, an easy-to-use Insulin Delivery Device for Diabetes Patients


Eli Lilly and Company ("Lilly") announced the launch of HumaPen® LUXURA™ HD, an easy-to-use insulin delivery device for patients who may require the precision of half-unit dosing (HD). The new dosing feature enhances safety and accuracy in maintaining glycemic control for patients, especially children with diabetes.
LUXURA HD, a reusable pen, delivers 0.5 to 30 units of insulin in half-unit increments, and is for use with Lilly Insulins [Humalog (Insulin Lispro) or Huminsulin (Insulin Human)]. The device comes with a unique dosing dial that can be moved forward as well as backward, without the loss of insulin.

According to the International Diabetes Federation (IDF), in 2010, approximately 3.80 Lakh children in India (between the Age group 0-14yrs) are projected to be suffering with Type 1 Diabetes. Living with this medical condition poses an enormous challenge for every member of the family. Now with the assurance of half unit dose provided by LUXURA HD, these patients would get the much needed medical and emotional support in their journey for successful management of this disease.

For children with Type 1 diabetes, their journey can often be overwhelming and difficult to manage. The company is pleased to introduce LUXURA HD which provides type 1 patients with the confidence and assurance of an accurate delivery of insulin.

No comments:

Post a Comment